PhoenixBio Co (TSE:6190) GF Value Rank: 10 (As of Aug. 24, 2026) — 150% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6190 PhoenixBio Co Ltd TSE:6190
51 GF Score
Price 円346.00
GF Value 円362.87
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is PhoenixBio Co GF Value Rank?

PhoenixBio Co TSE:6190 -0.57% 51 GF Value Rank is 10 as of Aug. 24, 2026, which is 150% above its 10-year median of 4.00. GuruFocus rates TSE:6190 with a GF Score™ of 51/100 and a GF Value™ of 円362.87 (Fairly Valued). The stock has 3 warning signs investors should review.

PhoenixBio Co has the GF Value Rank of 10.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


PhoenixBio Co GF Value Rank Related Terms


TSE:6190 vs VRTX, REGN, RVMD: GF Value Rank Comparison

For the Biotechnology subindustry, PhoenixBio Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's GF Value Rank falls into.


TSE:6190
51GF Score
PhoenixBio Co Ltd TSE:6190
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 10 mean?
PhoenixBio Co (TSE:6190) has a GF Value Rank of 10 as of Aug. 24, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on PhoenixBio Co and its competitors. This is 150% above median its historical median of 4.00. Over the past decade, PhoenixBio Co's GF Value Rank has ranged from 2.00 to 10.00.
Is PhoenixBio Co's GF Value Rank too high?
PhoenixBio Co's current GF Value Rank of 10 is 150% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, PhoenixBio Co has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's GF Value Rank compare to VRTX and REGN?
PhoenixBio Co's GF Value Rank of 10 can be compared against companies in the Biotechnology industry. Historically, PhoenixBio Co's own GF Value Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current GF Value Rank is 10, which is 150% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円362.87, compared to a current price of 円346.00 — trading 4.6% below its estimated fair value. The current GF Value Rank is 10, which is 150% above median its 10-year median of 4.00. PhoenixBio Co's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current GF Value Rank is 10 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円346.00 is trading 4.6% below its estimated GF Value™ of 円362.87. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • GF Value Rank: 10 (150% above median its 10-year median of 4.00)
  • GF Value™: 円362.87 vs. price of 円346.00 (4.6% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
51GF Score

Get the complete analysis for TSE:6190

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円346.00
Price
円362.87
GF Value